Navigation Links
New Stroke Treatment Enables People Who Have Been Confined to a Wheelchair to Walk Again Utilizing Stretching Therapy Together With Perispinal Etanercept Injections

(PRWEB) October 23, 2013

Phillip Koss, owner of is quick to point out that this process is no panacea. A severely disabled individual will need weeks of daily treatments, as much as two hours twice daily. Commitment and dedication is required of both the patient and practitioner. Each session is individually tailored to meet the specific needs of the person at each stage in the process. Since 2009, Stretch for Life has been enabling persons with stroke and traumatic brain injury (TBI) to regain feeling and function. The process involves full body stretching, massage, acupressure, strength training coupled with mental focus, breathing and visualization to eliminate spasticity and restore feeling and muscle function. Once the habitually tight muscles have been coaxed into relaxing, the relaxation is permanent. Persons who have been in chronic pain report the pain is alleviated.The process begins as a series of treatments to relax the tight muscles and continues as a relearning to use the atrophied muscles. Lastly, the procedure involves exercises to restore strength and coordination.

"By pretreating a client with perispinally administered etanercept (Enbrel), we vastly speed up the entire process and obtain results that would not be possible without the Enbrel," stated Phillip Koss a ATQDA certified motor skills specialist. For example, an individual with stroke who is completely unable to walk and confined to a wheelchair could, after a series of daily treatments over several months, walk with a walker or even crutches. When such an individual is pretreated with perispinally administered Enbrel, the treatment is shortened from several months to a few weeks and the individual may be able to walk entirely unaided. Some of these people have been so pleased with their outcomes they have contacted various news media. A collection of these reports appeared in:

There is a growing body of evidence linking chronic inflammatory events in the brain with many of the impairments persons with stroke and TBI experience. Enbrel is a drug approved to treat the acute inflammatory processes involved in certain forms of arthritis and psoriasis. Newly published research* finds: "The stroke and TBI induced cerebral ischemia, neurological motor deficits, and increased numbers of microglia-TNF-alpha double positive cells and increased TNF-alpha levels in the injured brain were all significantly attenuated by etanercept therapy." Rolando Hernandez M.D., a neurosurgeon at Neurological Wellness Center, states, "This research elucidates the neurological mechanisms that enable improvements in walking ability, arm movement, speech, mood, and reductions in spasticity that we see in the patients we have treated with perispinally administered Enbrel brand etanercept. The treatment protocol utilized by Neurological Wellness Center was pioneered by Edward Tobinick M.D. in 2006 and described in Expert Reviews of Neurotherapeutics.

"Stroke and TBI result in a self-perpetuating cycle of inflammation in the brain. This excess inflammation persists for years or even decades after the injury. This excess inflammation contributes to a portion of the many impairments our patients experience. Perispinally administered Enbrel reduces this inflammation in the brain, facilitating a recovery of function," stated Rolando Hernandez, M.D.

"These results represent a sea change in the therapeutic possibilities for stroke and TBI patients. Our team observed firsthand, rapid clinical improvement in stroke patients following this brief office treatment," said Dr. Steve Ralph, professor at Griffith University School of Medical Science in Austrailia. Dr. Ralph visited Neurological Wellness Center in Managua, Nicaragua in 2012 where he learned to perform perispinal injections," said Dr. Augusto Ramirez, M.D. of Neurological Wellness Center. Neurological Wellness Center physicians began teaching perispinal injection technique for the drug Enbrel in 2010. Since then physicians, nurses and caregivers from every continent have visited the center. "We have amassed a trove of anecdotal reports confirming the efficacy of perispinally injected Enbrel for the treatment of stroke and TBI," said Dr. Ramirez.

"Perispinal Enbrel as a TBI treatment has many attributes. (1) The therapeutic window is wide. A person whose injury occurred a decade ago or even longer may still benefit. (2) The treatment is short term, yet the benefits are long-lasting. (3) The dosage of Enbrel needed to achieve these results is quite low compared to the FDA recommendations for moderate plaque psoriasis. The FDA protocol for moderate plaque psoriasis calls for 24 injections totaling 1200 mg of Enbrel over a three-month period, followed by weekly injections for life. Whereas a person with moderate to severe stroke or TBI would need a maximum of 4 injections totaling 100 mg of Enbrel in this period and would be unlikely to need even a single booster injection. (4) The recovery - improvements can begin to occur in minutes and can build with subsequent injections over a four- to eight-week period," stated Dr. Hernandez.

Neurological Wellness Center offers a complete two-hour course on stroke treatment and traumatic brain injury treatment covering all aspects of perispinal injection technique at their Neurological Wellness Center in Managua, Nicaragua.

For many, flying to the Neurological Wellness Center in Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Neurological Wellness Center’s perispinal Enbrel is profoundly effective as a stroke treatment and TBI treatment.The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. Enbrel is a highly advertised, commonly prescribed drug manufactured by Immunex for Amgen/Pfizer. Over 400,000 Americans self-inject Enbrel each week, mostly as a treatment for rheumatoid arthritis. Enbrel is a powerful anti-inflammatory agent. Dr. Augusto believes many of the impairments people with TBI or stroke experience are due to a self-perpetuating cascade of inflammation that was initiated by the brain injury. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. "Fortunately for the millions of people now afflicted with stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel," said Dr. Rolando Hernandez M.D.

To enroll in a hands-on instructional course on perispinal injections, visit

To purchase an instructional video and e-book on administering perispinal injections, visit

To schedule an appointment with strechforlife at their office in Waco, Texas, visit: or call: 254-717-0641


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Flu shot halves risk of heart attack or stroke in people with history of heart attack, study finds
2. Flu shot halves risk of heart attack or stroke in people with history of heart attack, study finds
3. Excessive alcohol consumption increases the progression of atherosclerosis and the risk of stroke
4. Tests in mice identify compound that may keep survivors of brain aneurysms from succumbing to stroke
5. Telestroke service increases rates of clot-buster treatment for stroke, reports Neurosurgery
6. Birmingham Personal Injury Lawyers of Belt Law Firm, P.C., Discuss New Studies on Link between Strokes, TBI
7. YogaFit and The American Heart Association Collaborate to Raise Heart and Stroke Health Awareness in Southern California
8. Acute Ischemic Stroke Market (AIS): Analyzed and 2022 Forecasts in New Research Report at
9. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
10. Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke
11. MRI may predict heart attack and stroke risk in people with diabetes
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... GKhair & Tibolli ... the San Juan Beauty Show held on November 8th and 9th at the Puerto ... media personalities, hair artists, renowned beauticians and top of the line fashion journalists. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced today that ... Program with competencies in the Application Development, demonstrating a “best-in-class” ability and ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... product dealer. Joining more than 30 HealthPostures’ dealers located throughout the United States, ... increase the number of corporate, industrial, manufacturing and government workers and organizational leaders ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... patented products, announces the Unstoppable Swappables, a household invention that provides an economical ... $2 billion a year and is growing at 2.6%," says Scott Cooper, CEO ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Elbit Imaging Ltd. (TASE, NASDAQ: ... that it was informed by InSightec Ltd. ("InSightec"), that the ... approved its Exablate Neuro system to treat movement, pain ... --> Insightec,s Exablate Neuro platform is transforming medicine ... technologies: Focused Ultrasound, which is used to lesion the ...
(Date:11/29/2015)... 29, 2015   Royal Philips  (NYSE: PHG, AEX: ... at the 2015 Radiological Society of North America Annual ... Place in Chicago . Visitors to ... company,s broad portfolio of integrated Diagnostic Imaging, Clinical Informatics, ... clinical performance, improve workflow and create a superior patient ...
(Date:11/29/2015)... , Nov. 29, 2015 CIVCO Medical ... technology at the Radiological Society of ... Chicago November 29 – December ... designed to offer customers unrivaled versatility, enhanced user ... --> ...
Breaking Medicine Technology: